SCHEMBL4487333

SCHEMBL4487333

CN1CCN(Cc2ccc(N/C(=C3\C(=O)Nc4cc(Br)ccc43)c3ccccc3)cc2)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 2/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
RAB9A P51151 2/20 0.43
GAA P10253 1/20 0.43
HTT P42858 1/20 0.43
RET P07949 1/20 0.43
ACHE P22303 1/20 0.43
HDAC1 Q13547 1/20 0.42
FLT3 P36888 2/20 0.41
CDK2 P24941 1/20 0.41
CCNA1 P78396 1/20 0.41
KDR P35968 1/20 0.41
POLB P06746 2/20 0.41
NPC1 O15118 1/20 0.41
TP53 P04637 1/20 0.41
BTK Q06187 1/20 0.41
HDAC6 Q9UBN7 1/20 0.40
NTRK1 P04629 1/20 0.40
EGFR P00533 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4487341 1.00 FAAH (0.44) FAAHMEN1KMT2ARAB9AGAA
SCHEMBL4497909 0.92 GAA (0.53) FAAHMEN1KMT2ARAB9AGAA
SCHEMBL4497904 0.92 GAA (0.53) FAAHMEN1KMT2ARAB9AGAA
SCHEMBL4493644 0.91 PLK1 (0.46) FAAHRETACHEHDAC1FLT3
SCHEMBL4493647 0.91 PLK1 (0.46) FAAHRETACHEHDAC1FLT3
SCHEMBL4481621 0.91 GAA (0.54) FAAHMEN1KMT2ARAB9AGAA
SCHEMBL4485762 0.91 GAA (0.54) FAAHMEN1KMT2ARAB9AGAA
SCHEMBL30979383 0.91 GAA (0.54) FAAHMEN1KMT2ARAB9AGAA
SCHEMBL2571817 0.90 RET (0.46) MEN1KMT2ARAB9ARETACHE
SCHEMBL4494567 0.90 NTRK1 (0.44) FAAHRAB9ARETACHEHDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514468-B2 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2009-04-07 US disclosed
US-20060194813-A1 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2006-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060194813-A1 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions KDR, FLT1, EGFR FAAH 4521/4885MEN1 1288/4885KMT2A 3530/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.